Related Experiment Videos
[Percutaneous mitral valvulotomy]
1Departamento de Hemodinámica, Instituto Nacional de Cardiología Ignacio Chávez, INCICH, Juan Badiano No. 1, 14080 México, D.F.
Insights
Percutaneous balloon mitral valvotomy is the preferred treatment for mitral stenosis, offering excellent long-term results comparable to surgery. Meticulous patient selection ensures optimal outcomes for this minimally invasive procedure.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Procedures
Context:
- Mitral stenosis management
- Percutaneous balloon mitral valvotomy (PBMV) as first-line therapy
- Surgical vs. percutaneous interventions
Purpose:
- To evaluate the long-term efficacy and outcomes of PBMV in mitral stenosis patients
- To identify patient subgroups benefiting most from PBMV
- To compare PBMV results with historical surgical data
Summary:
- PBMV is the primary treatment for mitral stenosis, with high success rates in carefully selected patients.
- Long-term follow-up of 127 patients over five years demonstrated very favorable results.
- The procedure's outcomes are comparable to surgical closed mitral commissurotomy.
Impact:
- Establishes PBMV as a highly effective and durable treatment for mitral stenosis.
- Highlights the importance of patient selection for maximizing PBMV success.
- Provides evidence supporting PBMV as a viable alternative to surgery for suitable candidates.
Abstract:
Percutaneous balloon mitral valvotomy has become the first choice option for the treatment of mitral stenosis. Any patient with the disease is a candidate for the procedure. However there are patient's subgroups which the procedure success will reach a 100% accordingly to a meticulous selection of the cases. Long-term results has been excellent and may be compared with those of surgical closed mitral commissurotomy. We report our long-term follow-up experience of 127 patients followed during a mean of five years in which results have been very favorable.